Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
Newborn bloodspot screening (NBS) for cystic fibrosis (CF) is an effective strategy for the early recognition of infants with a CF diagnosis. Some infants with a positive NBS result for CF have an inconclusive diagnosis and evidence suggests the number of these infants is increasing, as more extensi...
Guardado en:
Autores principales: | Aditi Sinha, Kevin W. Southern |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3517d47adcba4f58b4ead0de31342077 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Maryam Hassanzad, et al.
Publicado: (2021) -
Delayed HIV diagnosis in a cystic fibrosis patient: Not just another exacerbation
por: Sapna Bhatia, et al.
Publicado: (2021) -
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt BZ, et al.
Publicado: (2016) -
Acquired cystic fibrosis transmembrane conductance regulator dysfunction
por: Catherine Banks, et al.
Publicado: (2018) -
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
por: Serena Schippa, et al.
Publicado: (2013)